Hypermethylation and global remodelling of DNA methylation is associated with acquired cisplatin resistance in testicular germ cell tumours

References

• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424.
   Google Scholar
• Adra N, Einhorn LH. Testicular cancer update. Clin Adv Hematol Oncol. 2017;15:386–396.
   Google Scholar
• Lavoie JM, Kollmannsberger CK. current management of disseminated germ cell tumors. Urol Clin North Am. 2019;46:377–388.
   Google Scholar
• Feldman DR, Patil S, Trinos MJ, et al. Progression-free and overall survival in patients with relapsed/refractory germ cell tumors treated with single-agent chemotherapy: endpoints for clinical trial design. Cancer. 2012;118:981–986.
   Google Scholar
• Allen JC, Kirschner A, Scarpato KR, et al. Current management of refractory germ cell tumors and future directions. Curr Oncol Rep. 2017;19:8.
   Google Scholar
• O’Shaughnessy MJ, Feldman DR, Carver BS, et al. Late relapse of testicular germ cell tumors. Urol Clin North Am. 2015;42:359–368.
   Google Scholar
• Fung C, Dinh PC, Fossa SD, et al. Testicular cancer survivorship. J Natl Compr Canc Netw. 2019;17:1557–1568.
   Google Scholar
• Batool A, Karimi N, Wu XN, et al. Testicular germ cell tumor: a comprehensive review. Cell Mol Life Sci. 2019;76:1713–1727.
   Google Scholar
• Rijlaarsdam MA, Looijenga LH. An oncofetal and developmental perspective on testicular germ cell cancer. Semin Cancer Biol. 2014;29:59–74.
   Google Scholar
• de Vries G, Rosas-Plaza X, van Vugt MATM, et al. Testicular cancer: determinants of cisplatin sensitivity and novel therapeutic opportunities. Cancer Treat Rev. 2020;88:102054.
   Google Scholar
• Lobo J, Jerónimo C, Henrique R. Cisplatin resistance in testicular germ cell tumors: current challenges from various perspectives. Cancers (Basel). 2020 June 17;12:1601.
   Google Scholar
• Singh R, Fazal Z, Freemantle SJ, et al. Mechanisms of cisplatin sensitivity and resistance in testicular germ cell tumors. Cancer Drug Resist. 2019;3:580–594.
   Google Scholar
• Loveday C, Litchfield K, Proszek PZ, et al. Genomic landscape of platinum resistant and sensitive testicular cancers. Nat Commun. 2020;11:2189.
   Google Scholar
• Shen H, Shih J, Hollern DP, et al. Integrated molecular characterization of testicular germ cell tumors. Cell Rep. 2018;23:3392–3406.
   Google Scholar
• Killian JK, Dorssers LC, Trabert B, et al. Imprints and DPPA3 are bypassed during pluripotency- and differentiation-coupled methylation reprogramming in testicular germ cell tumors. Genome Res. 2016; 26:1490–1504.
   Google Scholar
• van der Zwan YG, Rijlaarsdam MA, Rossello FJ, et al. Seminoma and embryonal carcinoma footprints identified by analysis of integrated genome-wide epigenetic and expression profiles of germ cell cancer cell lines. PLoS One. 2014;9:e98330.
   Google Scholar
• Koul S, McKiernan JM, Narayan G, et al. Role of promoter hypermethylation in cisplatin treatment response of male germ cell tumors. Mol Cancer. 2004;3:16.
   Google Scholar
• Martinelli CM, Lengert AV, Cárcano FM, et al. MGMT and CALCA promoter methylation are associated with poor prognosis in testicular germ cell tumor patients. Oncotarget. 2016;8:50608–50617.
   Google Scholar
• Wermann WH, Stoop H, Gillis AJ, et al. Global DNA methylation in fetal human germ cells and germ cell tumours: association with differentiation and cisplatin resistance. J Pathol. 2010;221:433–442.
   Google Scholar
• Beyrouthy MJ, Garner KM, Hever MP, et al. High DNA methyltransferase 3B expression mediates 5-aza-deoxycytidine hypersensitivity in testicular germ cell tumors. Cancer Res. 2009;69:9360–9366.
   Google Scholar
• Biswal BK, Beyrouthy MJ, Hever-Jardine MP, et al. Acute hypersensitivity of pluripotent testicular cancer-derived embryonal carcinoma to low-dose 5-aza deoxycytidine is associated with global DNA damage-associated p53 activation, anti-pluripotency and DNA demethylation. PLoS One. 2012;7:e53003.
   Google Scholar
• Albany C, Hever-Jardine MP, von Herrmann KM, et al. Refractory testicular germ cell tumors are highly sensitive to the second generation DNA methylation inhibitor guadecitabine. Oncotarget. 2017;8:2949–2959.
   Google Scholar
• Wongtrakoongate P, Li J, Andrews PW. Aza-deoxycytidine induces apoptosis or differentiation via DNMT3B and targets embryonal carcinoma cells but not their differentiated derivatives. Br J Cancer. 2014;110:2131–2138.
   Google Scholar
• Oing C, Verem I, Mansour WY, et al. 5-azacitidine exerts prolonged pro-apoptotic effects and overcomes cisplatin-resistance in non-seminomatous germ cell tumor cells. Int J Mol Sci. 2018;20:E21.
   Google Scholar
• Lobo J, Gillis AJM, Jerónimo C, et al. Human germ cell tumors are developmental cancers: impact of epigenetics on pathobiology and clinic. Int J Mol Sci. 2019;20:pE258.
   Google Scholar
• Singh R, Fazal Z, Corbet AK, et al. Epigenetic remodeling through downregulation of polycomb repressive complex 2 mediates chemotherapy resistance in testicular germ cell tumors. Cancers (Basel). 2019;11:E796.
   Google Scholar
• Zhou W, Laird PW, Shen H. Comprehensive characterization, annotation and innovative use of Infinium DNA methylation beadchip probes. Nucleic Acids Res. 2017;45:e22.
   Google Scholar
• Zheng Y, Joyce BT, Liu L, et al. Prediction of genome-wide DNA methylation in repetitive elements. Nucleic Acids Res. 2017;45:8697–8711.
   Google Scholar
• Lee J-H, Park S-J, Nakai K. Differential landscape of non-CpG methylation in embryonic stem cells and neurons caused by DNMT3s. Sci Rep. 2017;7:11295.
   Google Scholar
• Sheffield NC, Bock C. LOLA: enrichment analysis for genomic region sets and regulatory elements in R and bioconductor. Bioinformatics. 2016;32:587–589.
   Google Scholar
• Madakashira BP, Sadler KC. DNA methylation, nuclear organization, and cancer. Front Genet. 2017;8:76.
   Google Scholar
• Cheng H, Zhang N, Pati D. Cohesin subunit RAD21: from biology to disease. Gene. 2020;758:144966.
   Google Scholar
• Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102:15545–15550.
   Google Scholar
• Schmidtova S, Kalavska K, Kucerova L. Molecular mechanisms of cisplatin chemoresistance and its circumventing in testicular germ cell tumors. Curr Oncol Rep. 2018;20:88.
   Google Scholar
• Jostes S, Nettersheim D, Schorle H. Epigenetic drugs and their molecular targets in testicular germ cell tumours. Nat Rev Urol. 2019;16:245–259.
   Google Scholar
• Ilijazi D, Shariat SF, Hassler MR, et al. Epigenetic alterations of testicular germ cell tumours. Curr Opin Urol. 2020;30:264–270.
   Google Scholar
• Marques-Magalhães Â, Graça I, Henrique R, et al. Targeting DNA methyltransferases in urological tumors. Front Pharmacol. 2018;9:366.
   Google Scholar
• Ishak CA, Classon M, De Carvalho DD. Deregulation of retroelements as an emerging therapeutic opportunity in cancer. Trends Cancer. 2018;4:583–597.
   Google Scholar
• Lochs SJA, Kefalopoulou S, Kind J. Lamina associated domains and gene regulation in development and cancer. Cells. 2019;8:271.
   Google Scholar
• Jones PA, Issa J-PJ, Baylin S. Targeting the cancer epigenome for therapy. Nat Rev Genet. 2016;17:630–641.
   Google Scholar
• Spainhour JC, Lim HS, Yi SV, et al. Correlation patterns between DNA methylation and gene expression in the cancer genome atlas. Cancer Inform. 2019;11:18.
   Google Scholar
• Bo H, Cao K, Tang R, et al. A network-based approach to identify DNA methylation and its involved molecular pathways in testicular germ cell tumors. J Cancer. 2019;10:893–902.
   Google Scholar
• Ahmad F, Surve P, Natarajan S, et al. Aberrant epigenetic inactivation of RASSF1A and MGMT gene and genetic mutations of KRAS, cKIT and BRAF in Indian testicular germ cell tumours. Cancer Genet. 2020;241:42–50.
   Google Scholar
• Liu H, Liu X, Zhang S, et al. Systematic identification and annotation of human methylation marks based on bisulfite sequencing methylomes reveals distinct roles of cell type-specific hypomethylation in the regulation of cell identity genes. Nucleic Acids Res. 2016;44:75–94.
   Google Scholar
• Pinney SE. Mammalian non-CpG methylation: stem cells and beyond. Biology (Basel). 2014;3:739–751.
   Google Scholar
• JP T Jr, Hansen KD. Preprocessing, normalization and integration of the illumina HumanMethylationEPIC array with minfi. Bioinformatics. 2017;33:558–560.
   Google Scholar
• Fortin JP, Labbe A, Lemire M, et al. Functional normalization of 450k methylation array data improves replication in large cancer studies. Genome Biol. 2014;15:503.
   Google Scholar
• Chen YA, Lemire M, Choufani S, et al. Discovery of cross-reactive probes and polymorphic CpGs in the illumina infinium HumanMethylation450 microarray. Epigenetics. 2013;8:203–209.
   Google Scholar